The primary finding from the clinical trials for the COPD biologics is reduced annual exacerbations by 30% (BOREAS trial) and 34% (NOTUS trial). In the BOREAS trial, in addition to reduced ...

Catherine O’Hara’s death at 71 sent shock waves throughout Hollywood. The comedic actor has been remembered by former “The ...

Managing mucus from COPD involves strategies that can help loosen mucus and clear it from your airway, such as staying ...

A pulmonary embolism tied to colorectal cancer killed Catherine O’Hara. Here’s how common the event is among cancer patients ...

Dr. Shune highlights that the growing availability of FDA-approved agents with distinct and complementary mechanisms has ...

A 38-year-old male patient was admitted to Father Muller Medical College and Hospital (FMMCH) after being diagnosed with right lower limb deep vein thrombosis (DVT). He had a history of breathlessness ...

From prior authorization delays to PBM reforms and Medicaid gaps, experts track policy shifts that shape health equity and ...

GSK’s Nucala receives European Commission approval to treat chronic obstructive pulmonary disease: London, UK Saturday, February 7, 2026, 09:00 Hrs [IST] GSK plc announced the E ...

Last week, the leading developers of treatments for atrial fibrillation (AFib) convened in Boston for the 2026 AF Symposium.

From partial heart transplantation and complex biventricular repairs to innovative procedures in the catheterization ...

Johnson & Johnson, Boston Scientific and Abbott were among the companies showcasing new data on atrial fibrillation ...